Global Pretomanid Tablets Market Growth 2026-2032
The global Pretomanid Tablets market size is predicted to grow from US$ 176 million in 2025 to US$ 394 million in 2032; it is expected to grow at a CAGR of 10.6% from 2026 to 2032.
Pretomanid tablets are a novel nitroimidazopyran anti-tuberculosis drug with potent bactericidal activity against multidrug-resistant tuberculosis. It exerts a bactericidal effect by inhibiting the synthesis of proteins and cell walls of Mycobacterium tuberculosis. As a core drug in the fully oral, long-course anti-tuberculosis regimen, it is often combined with bedaquiline and linezolid to form the BPaL regimen, for the treatment of extensively drug-resistant pulmonary tuberculosis or multidrug-resistant pulmonary tuberculosis with intolerance or ineffective conventional treatment. Featuring favorable oral absorption, strong tissue penetration and controllable safety, it is a core therapeutic drug for drug-resistant tuberculosis recommended by WHO, which significantly improves the cure rate of refractory tuberculosis.In 2025, global Pretomanid tablets production reached approximately 1,200,000 bottles
As an innovative drug in the global anti-tuberculosis field, Pretomanid tablets are strategically positioned and developed based on the clinical demand for drug-resistant tuberculosis and the construction of public health systems. As a core component of the fully oral, short-course BPaL (or BPaLM) combination regimen, Pretomanid is mainly indicated for multidrug-resistant and extensively drug-resistant tuberculosis. With superior efficacy and safety compared with traditional regimens, it has become a core drug recommended by the World Health Organization for drug-resistant tuberculosis, driving the global shift from long-course, high-adverse-effect tuberculosis treatments to short-course, high-compliance regimens.
In terms of market structure, the global market features a diversified supply pattern of innovator and generic drugs. The originator product developed by TB Alliance expands coverage in high-burden countries and low- and middle-income markets through multi-manufacturer authorization. Meanwhile, generic drugs qualified by WHO prequalification significantly improve drug accessibility via international public health procurement and regional supply chains, forming a supply system dominated by public health programs. In China, the approval and inclusion of Pretomanid in the medical insurance catalogue have substantially improved diagnosis and treatment accessibility and reduced patient burden, advancing domestic drug-resistant tuberculosis prevention and control into a new stage of highly effective and inclusive treatment.
The core drivers of market growth lie in three aspects: first, the persistent global incidence of drug-resistant tuberculosis sustains strong demand for new and effective treatment regimens; second, countries gradually incorporate BPaL-based short-course regimens into national tuberculosis programs, accelerating clinical adoption and policy implementation; third, price optimization and multi-manufacturer deployment balance drug value and healthcare system costs, expanding accessibility. Meanwhile, market development faces challenges such as regional disparities in medical resources, standardized management of treatment regimens, and improvement of drug resistance monitoring systems. Further consolidation of its core position in drug-resistant tuberculosis therapy relies on public health cooperation, improved cross-regional supply chains, and continuous accumulation of real-world data.
LP Information, Inc. (LPI) ' newest research report, the ?Pretomanid Tablets Industry Forecast? looks at past sales and reviews total world Pretomanid Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Pretomanid Tablets sales for 2026 through 2032. With Pretomanid Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pretomanid Tablets industry.
This Insight Report provides a comprehensive analysis of the global Pretomanid Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pretomanid Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Pretomanid Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pretomanid Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pretomanid Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Pretomanid Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Pretomanid Tablets market?
What factors are driving Pretomanid Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pretomanid Tablets market opportunities vary by end market size?
How does Pretomanid Tablets break out by Type, by Application?
Pretomanid tablets are a novel nitroimidazopyran anti-tuberculosis drug with potent bactericidal activity against multidrug-resistant tuberculosis. It exerts a bactericidal effect by inhibiting the synthesis of proteins and cell walls of Mycobacterium tuberculosis. As a core drug in the fully oral, long-course anti-tuberculosis regimen, it is often combined with bedaquiline and linezolid to form the BPaL regimen, for the treatment of extensively drug-resistant pulmonary tuberculosis or multidrug-resistant pulmonary tuberculosis with intolerance or ineffective conventional treatment. Featuring favorable oral absorption, strong tissue penetration and controllable safety, it is a core therapeutic drug for drug-resistant tuberculosis recommended by WHO, which significantly improves the cure rate of refractory tuberculosis.In 2025, global Pretomanid tablets production reached approximately 1,200,000 bottles
As an innovative drug in the global anti-tuberculosis field, Pretomanid tablets are strategically positioned and developed based on the clinical demand for drug-resistant tuberculosis and the construction of public health systems. As a core component of the fully oral, short-course BPaL (or BPaLM) combination regimen, Pretomanid is mainly indicated for multidrug-resistant and extensively drug-resistant tuberculosis. With superior efficacy and safety compared with traditional regimens, it has become a core drug recommended by the World Health Organization for drug-resistant tuberculosis, driving the global shift from long-course, high-adverse-effect tuberculosis treatments to short-course, high-compliance regimens.
In terms of market structure, the global market features a diversified supply pattern of innovator and generic drugs. The originator product developed by TB Alliance expands coverage in high-burden countries and low- and middle-income markets through multi-manufacturer authorization. Meanwhile, generic drugs qualified by WHO prequalification significantly improve drug accessibility via international public health procurement and regional supply chains, forming a supply system dominated by public health programs. In China, the approval and inclusion of Pretomanid in the medical insurance catalogue have substantially improved diagnosis and treatment accessibility and reduced patient burden, advancing domestic drug-resistant tuberculosis prevention and control into a new stage of highly effective and inclusive treatment.
The core drivers of market growth lie in three aspects: first, the persistent global incidence of drug-resistant tuberculosis sustains strong demand for new and effective treatment regimens; second, countries gradually incorporate BPaL-based short-course regimens into national tuberculosis programs, accelerating clinical adoption and policy implementation; third, price optimization and multi-manufacturer deployment balance drug value and healthcare system costs, expanding accessibility. Meanwhile, market development faces challenges such as regional disparities in medical resources, standardized management of treatment regimens, and improvement of drug resistance monitoring systems. Further consolidation of its core position in drug-resistant tuberculosis therapy relies on public health cooperation, improved cross-regional supply chains, and continuous accumulation of real-world data.
LP Information, Inc. (LPI) ' newest research report, the ?Pretomanid Tablets Industry Forecast? looks at past sales and reviews total world Pretomanid Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Pretomanid Tablets sales for 2026 through 2032. With Pretomanid Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pretomanid Tablets industry.
This Insight Report provides a comprehensive analysis of the global Pretomanid Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pretomanid Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Pretomanid Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pretomanid Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pretomanid Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Pretomanid Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 26 tablets/box
- 182 tablets/bottle
- Bottle
- Box
- Protect From Light
- Protect From Moisture
- Innovator
- Generic
- Multidrug-Resistant Pulmonary Tuberculosis (MDR-TB)
- Extensively Drug-Resistant Pulmonary Tuberculosis (XDR-TB)
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- TB Alliance
- Macleods Pharmaceuticals
- Lupin Limited
What is the 10-year outlook for the global Pretomanid Tablets market?
What factors are driving Pretomanid Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pretomanid Tablets market opportunities vary by end market size?
How does Pretomanid Tablets break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pretomanid Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Pretomanid Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Pretomanid Tablets by Country/Region, 2021, 2025 & 2032
2.2 Pretomanid Tablets Segment by Type
2.2.1 26 tablets/box
2.2.2 182 tablets/bottle
2.2.3 Pretomanid Tablets Sales by Type
2.2.3.1 Global Pretomanid Tablets Sales Market Share by Type (2021-2026)
2.2.3.2 Global Pretomanid Tablets Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Pretomanid Tablets Sale Price by Type (2021-2026)
2.3 Pretomanid Tablets Segment by Packaging
2.3.1 Bottle
2.3.2 Box
2.3.3 Pretomanid Tablets Sales by Packaging
2.3.3.1 Global Pretomanid Tablets Sales Market Share by Packaging (2021-2026)
2.3.3.2 Global Pretomanid Tablets Revenue and Market Share by Packaging (2021-2026)
2.3.3.3 Global Pretomanid Tablets Sale Price by Packaging (2021-2026)
2.4 Pretomanid Tablets Segment by Storage
2.4.1 Protect From Light
2.4.2 Protect From Moisture
2.4.3 Pretomanid Tablets Sales by Storage
2.4.3.1 Global Pretomanid Tablets Sales Market Share by Storage (2021-2026)
2.4.3.2 Global Pretomanid Tablets Revenue and Market Share by Storage (2021-2026)
2.4.3.3 Global Pretomanid Tablets Sale Price by Storage (2021-2026)
2.5 Pretomanid Tablets Segment by Production Technology
2.5.1 Innovator
2.5.2 Generic
2.5.3 Pretomanid Tablets Sales by Production Technology
2.5.3.1 Global Pretomanid Tablets Sales Market Share by Production Technology (2021-2026)
2.5.3.2 Global Pretomanid Tablets Revenue and Market Share by Production Technology (2021-2026)
2.5.3.3 Global Pretomanid Tablets Sale Price by Production Technology (2021-2026)
2.6 Pretomanid Tablets Segment by Application
2.6.1 Multidrug-Resistant Pulmonary Tuberculosis (MDR-TB)
2.6.2 Extensively Drug-Resistant Pulmonary Tuberculosis (XDR-TB)
2.6.3 Others
2.6.4 Pretomanid Tablets Sales by Application
2.6.4.1 Global Pretomanid Tablets Sale Market Share by Application (2021-2026)
2.6.4.2 Global Pretomanid Tablets Revenue and Market Share by Application (2021-2026)
2.6.4.3 Global Pretomanid Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Pretomanid Tablets Breakdown Data by Company
3.1.1 Global Pretomanid Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Pretomanid Tablets Sales Market Share by Company (2021-2026)
3.2 Global Pretomanid Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Pretomanid Tablets Revenue by Company (2021-2026)
3.2.2 Global Pretomanid Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Pretomanid Tablets Sale Price by Company
3.4 Key Manufacturers Pretomanid Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pretomanid Tablets Product Location Distribution
3.4.2 Players Pretomanid Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PRETOMANID TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Pretomanid Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Pretomanid Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Pretomanid Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Pretomanid Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Pretomanid Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Pretomanid Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pretomanid Tablets Sales Growth
4.4 APAC Pretomanid Tablets Sales Growth
4.5 Europe Pretomanid Tablets Sales Growth
4.6 Middle East & Africa Pretomanid Tablets Sales Growth
5 AMERICAS
5.1 Americas Pretomanid Tablets Sales by Country
5.1.1 Americas Pretomanid Tablets Sales by Country (2021-2026)
5.1.2 Americas Pretomanid Tablets Revenue by Country (2021-2026)
5.2 Americas Pretomanid Tablets Sales by Type (2021-2026)
5.3 Americas Pretomanid Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pretomanid Tablets Sales by Region
6.1.1 APAC Pretomanid Tablets Sales by Region (2021-2026)
6.1.2 APAC Pretomanid Tablets Revenue by Region (2021-2026)
6.2 APAC Pretomanid Tablets Sales by Type (2021-2026)
6.3 APAC Pretomanid Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pretomanid Tablets by Country
7.1.1 Europe Pretomanid Tablets Sales by Country (2021-2026)
7.1.2 Europe Pretomanid Tablets Revenue by Country (2021-2026)
7.2 Europe Pretomanid Tablets Sales by Type (2021-2026)
7.3 Europe Pretomanid Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pretomanid Tablets by Country
8.1.1 Middle East & Africa Pretomanid Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Pretomanid Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Pretomanid Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Pretomanid Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pretomanid Tablets
10.3 Manufacturing Process Analysis of Pretomanid Tablets
10.4 Industry Chain Structure of Pretomanid Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pretomanid Tablets Distributors
11.3 Pretomanid Tablets Customer
12 WORLD FORECAST REVIEW FOR PRETOMANID TABLETS BY GEOGRAPHIC REGION
12.1 Global Pretomanid Tablets Market Size Forecast by Region
12.1.1 Global Pretomanid Tablets Forecast by Region (2027-2032)
12.1.2 Global Pretomanid Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Pretomanid Tablets Forecast by Type (2027-2032)
12.7 Global Pretomanid Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 TB Alliance
13.1.1 TB Alliance Company Information
13.1.2 TB Alliance Pretomanid Tablets Product Portfolios and Specifications
13.1.3 TB Alliance Pretomanid Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 TB Alliance Main Business Overview
13.1.5 TB Alliance Latest Developments
13.2 Macleods Pharmaceuticals
13.2.1 Macleods Pharmaceuticals Company Information
13.2.2 Macleods Pharmaceuticals Pretomanid Tablets Product Portfolios and Specifications
13.2.3 Macleods Pharmaceuticals Pretomanid Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Macleods Pharmaceuticals Main Business Overview
13.2.5 Macleods Pharmaceuticals Latest Developments
13.3 Lupin Limited
13.3.1 Lupin Limited Company Information
13.3.2 Lupin Limited Pretomanid Tablets Product Portfolios and Specifications
13.3.3 Lupin Limited Pretomanid Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Lupin Limited Main Business Overview
13.3.5 Lupin Limited Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pretomanid Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Pretomanid Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Pretomanid Tablets by Country/Region, 2021, 2025 & 2032
2.2 Pretomanid Tablets Segment by Type
2.2.1 26 tablets/box
2.2.2 182 tablets/bottle
2.2.3 Pretomanid Tablets Sales by Type
2.2.3.1 Global Pretomanid Tablets Sales Market Share by Type (2021-2026)
2.2.3.2 Global Pretomanid Tablets Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Pretomanid Tablets Sale Price by Type (2021-2026)
2.3 Pretomanid Tablets Segment by Packaging
2.3.1 Bottle
2.3.2 Box
2.3.3 Pretomanid Tablets Sales by Packaging
2.3.3.1 Global Pretomanid Tablets Sales Market Share by Packaging (2021-2026)
2.3.3.2 Global Pretomanid Tablets Revenue and Market Share by Packaging (2021-2026)
2.3.3.3 Global Pretomanid Tablets Sale Price by Packaging (2021-2026)
2.4 Pretomanid Tablets Segment by Storage
2.4.1 Protect From Light
2.4.2 Protect From Moisture
2.4.3 Pretomanid Tablets Sales by Storage
2.4.3.1 Global Pretomanid Tablets Sales Market Share by Storage (2021-2026)
2.4.3.2 Global Pretomanid Tablets Revenue and Market Share by Storage (2021-2026)
2.4.3.3 Global Pretomanid Tablets Sale Price by Storage (2021-2026)
2.5 Pretomanid Tablets Segment by Production Technology
2.5.1 Innovator
2.5.2 Generic
2.5.3 Pretomanid Tablets Sales by Production Technology
2.5.3.1 Global Pretomanid Tablets Sales Market Share by Production Technology (2021-2026)
2.5.3.2 Global Pretomanid Tablets Revenue and Market Share by Production Technology (2021-2026)
2.5.3.3 Global Pretomanid Tablets Sale Price by Production Technology (2021-2026)
2.6 Pretomanid Tablets Segment by Application
2.6.1 Multidrug-Resistant Pulmonary Tuberculosis (MDR-TB)
2.6.2 Extensively Drug-Resistant Pulmonary Tuberculosis (XDR-TB)
2.6.3 Others
2.6.4 Pretomanid Tablets Sales by Application
2.6.4.1 Global Pretomanid Tablets Sale Market Share by Application (2021-2026)
2.6.4.2 Global Pretomanid Tablets Revenue and Market Share by Application (2021-2026)
2.6.4.3 Global Pretomanid Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Pretomanid Tablets Breakdown Data by Company
3.1.1 Global Pretomanid Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Pretomanid Tablets Sales Market Share by Company (2021-2026)
3.2 Global Pretomanid Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Pretomanid Tablets Revenue by Company (2021-2026)
3.2.2 Global Pretomanid Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Pretomanid Tablets Sale Price by Company
3.4 Key Manufacturers Pretomanid Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pretomanid Tablets Product Location Distribution
3.4.2 Players Pretomanid Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PRETOMANID TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Pretomanid Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Pretomanid Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Pretomanid Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Pretomanid Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Pretomanid Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Pretomanid Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pretomanid Tablets Sales Growth
4.4 APAC Pretomanid Tablets Sales Growth
4.5 Europe Pretomanid Tablets Sales Growth
4.6 Middle East & Africa Pretomanid Tablets Sales Growth
5 AMERICAS
5.1 Americas Pretomanid Tablets Sales by Country
5.1.1 Americas Pretomanid Tablets Sales by Country (2021-2026)
5.1.2 Americas Pretomanid Tablets Revenue by Country (2021-2026)
5.2 Americas Pretomanid Tablets Sales by Type (2021-2026)
5.3 Americas Pretomanid Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pretomanid Tablets Sales by Region
6.1.1 APAC Pretomanid Tablets Sales by Region (2021-2026)
6.1.2 APAC Pretomanid Tablets Revenue by Region (2021-2026)
6.2 APAC Pretomanid Tablets Sales by Type (2021-2026)
6.3 APAC Pretomanid Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pretomanid Tablets by Country
7.1.1 Europe Pretomanid Tablets Sales by Country (2021-2026)
7.1.2 Europe Pretomanid Tablets Revenue by Country (2021-2026)
7.2 Europe Pretomanid Tablets Sales by Type (2021-2026)
7.3 Europe Pretomanid Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pretomanid Tablets by Country
8.1.1 Middle East & Africa Pretomanid Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Pretomanid Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Pretomanid Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Pretomanid Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pretomanid Tablets
10.3 Manufacturing Process Analysis of Pretomanid Tablets
10.4 Industry Chain Structure of Pretomanid Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pretomanid Tablets Distributors
11.3 Pretomanid Tablets Customer
12 WORLD FORECAST REVIEW FOR PRETOMANID TABLETS BY GEOGRAPHIC REGION
12.1 Global Pretomanid Tablets Market Size Forecast by Region
12.1.1 Global Pretomanid Tablets Forecast by Region (2027-2032)
12.1.2 Global Pretomanid Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Pretomanid Tablets Forecast by Type (2027-2032)
12.7 Global Pretomanid Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 TB Alliance
13.1.1 TB Alliance Company Information
13.1.2 TB Alliance Pretomanid Tablets Product Portfolios and Specifications
13.1.3 TB Alliance Pretomanid Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 TB Alliance Main Business Overview
13.1.5 TB Alliance Latest Developments
13.2 Macleods Pharmaceuticals
13.2.1 Macleods Pharmaceuticals Company Information
13.2.2 Macleods Pharmaceuticals Pretomanid Tablets Product Portfolios and Specifications
13.2.3 Macleods Pharmaceuticals Pretomanid Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Macleods Pharmaceuticals Main Business Overview
13.2.5 Macleods Pharmaceuticals Latest Developments
13.3 Lupin Limited
13.3.1 Lupin Limited Company Information
13.3.2 Lupin Limited Pretomanid Tablets Product Portfolios and Specifications
13.3.3 Lupin Limited Pretomanid Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Lupin Limited Main Business Overview
13.3.5 Lupin Limited Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. PretomanidTablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. PretomanidTablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 26 tablets/box
Table 4. Major Players of 182 tablets/bottle
Table 5. Global PretomanidTablets Sales by Type (2021-2026) & (Units)
Table 6. Global PretomanidTablets Sales Market Share by Type (2021-2026)
Table 7. Global PretomanidTablets Revenue by Type (2021-2026) & ($ million)
Table 8. Global PretomanidTablets Revenue Market Share by Type (2021-2026)
Table 9. Global PretomanidTablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Bottle
Table 11. Major Players of Box
Table 12. Global PretomanidTablets Sales by Packaging (2021-2026) & (Units)
Table 13. Global PretomanidTablets Sales Market Share by Packaging (2021-2026)
Table 14. Global PretomanidTablets Revenue by Packaging (2021-2026) & ($ million)
Table 15. Global PretomanidTablets Revenue Market Share by Packaging (2021-2026)
Table 16. Global PretomanidTablets Sale Price by Packaging (2021-2026) & (US$/Unit)
Table 17. Major Players of Protect From Light
Table 18. Major Players of Protect From Moisture
Table 19. Global PretomanidTablets Sales by Storage (2021-2026) & (Units)
Table 20. Global PretomanidTablets Sales Market Share by Storage (2021-2026)
Table 21. Global PretomanidTablets Revenue by Storage (2021-2026) & ($ million)
Table 22. Global PretomanidTablets Revenue Market Share by Storage (2021-2026)
Table 23. Global PretomanidTablets Sale Price by Storage (2021-2026) & (US$/Unit)
Table 24. Major Players of Innovator
Table 25. Major Players of Generic
Table 26. Global PretomanidTablets Sales by Production Technology (2021-2026) & (Units)
Table 27. Global PretomanidTablets Sales Market Share by Production Technology (2021-2026)
Table 28. Global PretomanidTablets Revenue by Production Technology (2021-2026) & ($ million)
Table 29. Global PretomanidTablets Revenue Market Share by Production Technology (2021-2026)
Table 30. Global PretomanidTablets Sale Price by Production Technology (2021-2026) & (US$/Unit)
Table 31. Global PretomanidTablets Sale by Application (2021-2026) & (Units)
Table 32. Global PretomanidTablets Sale Market Share by Application (2021-2026)
Table 33. Global PretomanidTablets Revenue by Application (2021-2026) & ($ million)
Table 34. Global PretomanidTablets Revenue Market Share by Application (2021-2026)
Table 35. Global PretomanidTablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 36. Global PretomanidTablets Sales by Company (2021-2026) & (Units)
Table 37. Global PretomanidTablets Sales Market Share by Company (2021-2026)
Table 38. Global PretomanidTablets Revenue by Company (2021-2026) & ($ millions)
Table 39. Global PretomanidTablets Revenue Market Share by Company (2021-2026)
Table 40. Global PretomanidTablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 41. Key Manufacturers PretomanidTablets Producing Area Distribution and Sales Area
Table 42. Players PretomanidTablets Products Offered
Table 43. PretomanidTablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 44. New Products and Potential Entrants
Table 45. Market M&A Activity & Strategy
Table 46. Global PretomanidTablets Sales by Geographic Region (2021-2026) & (Units)
Table 47. Global PretomanidTablets Sales Market Share Geographic Region (2021-2026)
Table 48. Global PretomanidTablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 49. Global PretomanidTablets Revenue Market Share by Geographic Region (2021-2026)
Table 50. Global PretomanidTablets Sales by Country/Region (2021-2026) & (Units)
Table 51. Global PretomanidTablets Sales Market Share by Country/Region (2021-2026)
Table 52. Global PretomanidTablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 53. Global PretomanidTablets Revenue Market Share by Country/Region (2021-2026)
Table 54. Americas PretomanidTablets Sales by Country (2021-2026) & (Units)
Table 55. Americas PretomanidTablets Sales Market Share by Country (2021-2026)
Table 56. Americas PretomanidTablets Revenue by Country (2021-2026) & ($ millions)
Table 57. Americas PretomanidTablets Sales by Type (2021-2026) & (Units)
Table 58. Americas PretomanidTablets Sales by Application (2021-2026) & (Units)
Table 59. APAC PretomanidTablets Sales by Region (2021-2026) & (Units)
Table 60. APAC PretomanidTablets Sales Market Share by Region (2021-2026)
Table 61. APAC PretomanidTablets Revenue by Region (2021-2026) & ($ millions)
Table 62. APAC PretomanidTablets Sales by Type (2021-2026) & (Units)
Table 63. APAC PretomanidTablets Sales by Application (2021-2026) & (Units)
Table 64. Europe PretomanidTablets Sales by Country (2021-2026) & (Units)
Table 65. Europe PretomanidTablets Revenue by Country (2021-2026) & ($ millions)
Table 66. Europe PretomanidTablets Sales by Type (2021-2026) & (Units)
Table 67. Europe PretomanidTablets Sales by Application (2021-2026) & (Units)
Table 68. Middle East & Africa PretomanidTablets Sales by Country (2021-2026) & (Units)
Table 69. Middle East & Africa PretomanidTablets Revenue Market Share by Country (2021-2026)
Table 70. Middle East & Africa PretomanidTablets Sales by Type (2021-2026) & (Units)
Table 71. Middle East & Africa PretomanidTablets Sales by Application (2021-2026) & (Units)
Table 72. Key Market Drivers & Growth Opportunities of PretomanidTablets
Table 73. Key Market Challenges & Risks of PretomanidTablets
Table 74. Key Industry Trends of PretomanidTablets
Table 75. PretomanidTablets Raw Material
Table 76. Key Suppliers of Raw Materials
Table 77. PretomanidTablets Distributors List
Table 78. PretomanidTablets Customer List
Table 79. Global PretomanidTablets Sales Forecast by Region (2027-2032) & (Units)
Table 80. Global PretomanidTablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Americas PretomanidTablets Sales Forecast by Country (2027-2032) & (Units)
Table 82. Americas PretomanidTablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. APAC PretomanidTablets Sales Forecast by Region (2027-2032) & (Units)
Table 84. APAC PretomanidTablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 85. Europe PretomanidTablets Sales Forecast by Country (2027-2032) & (Units)
Table 86. Europe PretomanidTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. Middle East & Africa PretomanidTablets Sales Forecast by Country (2027-2032) & (Units)
Table 88. Middle East & Africa PretomanidTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 89. Global PretomanidTablets Sales Forecast by Type (2027-2032) & (Units)
Table 90. Global PretomanidTablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 91. Global PretomanidTablets Sales Forecast by Application (2027-2032) & (Units)
Table 92. Global PretomanidTablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 93. TB Alliance Basic Information, PretomanidTablets Manufacturing Base, Sales Area and Its Competitors
Table 94. TB Alliance PretomanidTablets Product Portfolios and Specifications
Table 95. TB Alliance PretomanidTablets Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. TB Alliance Main Business
Table 97. TB Alliance Latest Developments
Table 98. Macleods Pharmaceuticals Basic Information, PretomanidTablets Manufacturing Base, Sales Area and Its Competitors
Table 99. Macleods Pharmaceuticals PretomanidTablets Product Portfolios and Specifications
Table 100. Macleods Pharmaceuticals PretomanidTablets Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Macleods Pharmaceuticals Main Business
Table 102. Macleods Pharmaceuticals Latest Developments
Table 103. Lupin Limited Basic Information, PretomanidTablets Manufacturing Base, Sales Area and Its Competitors
Table 104. Lupin Limited PretomanidTablets Product Portfolios and Specifications
Table 105. Lupin Limited PretomanidTablets Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Lupin Limited Main Business
Table 107. Lupin Limited Latest Developments
Table 1. PretomanidTablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. PretomanidTablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 26 tablets/box
Table 4. Major Players of 182 tablets/bottle
Table 5. Global PretomanidTablets Sales by Type (2021-2026) & (Units)
Table 6. Global PretomanidTablets Sales Market Share by Type (2021-2026)
Table 7. Global PretomanidTablets Revenue by Type (2021-2026) & ($ million)
Table 8. Global PretomanidTablets Revenue Market Share by Type (2021-2026)
Table 9. Global PretomanidTablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Bottle
Table 11. Major Players of Box
Table 12. Global PretomanidTablets Sales by Packaging (2021-2026) & (Units)
Table 13. Global PretomanidTablets Sales Market Share by Packaging (2021-2026)
Table 14. Global PretomanidTablets Revenue by Packaging (2021-2026) & ($ million)
Table 15. Global PretomanidTablets Revenue Market Share by Packaging (2021-2026)
Table 16. Global PretomanidTablets Sale Price by Packaging (2021-2026) & (US$/Unit)
Table 17. Major Players of Protect From Light
Table 18. Major Players of Protect From Moisture
Table 19. Global PretomanidTablets Sales by Storage (2021-2026) & (Units)
Table 20. Global PretomanidTablets Sales Market Share by Storage (2021-2026)
Table 21. Global PretomanidTablets Revenue by Storage (2021-2026) & ($ million)
Table 22. Global PretomanidTablets Revenue Market Share by Storage (2021-2026)
Table 23. Global PretomanidTablets Sale Price by Storage (2021-2026) & (US$/Unit)
Table 24. Major Players of Innovator
Table 25. Major Players of Generic
Table 26. Global PretomanidTablets Sales by Production Technology (2021-2026) & (Units)
Table 27. Global PretomanidTablets Sales Market Share by Production Technology (2021-2026)
Table 28. Global PretomanidTablets Revenue by Production Technology (2021-2026) & ($ million)
Table 29. Global PretomanidTablets Revenue Market Share by Production Technology (2021-2026)
Table 30. Global PretomanidTablets Sale Price by Production Technology (2021-2026) & (US$/Unit)
Table 31. Global PretomanidTablets Sale by Application (2021-2026) & (Units)
Table 32. Global PretomanidTablets Sale Market Share by Application (2021-2026)
Table 33. Global PretomanidTablets Revenue by Application (2021-2026) & ($ million)
Table 34. Global PretomanidTablets Revenue Market Share by Application (2021-2026)
Table 35. Global PretomanidTablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 36. Global PretomanidTablets Sales by Company (2021-2026) & (Units)
Table 37. Global PretomanidTablets Sales Market Share by Company (2021-2026)
Table 38. Global PretomanidTablets Revenue by Company (2021-2026) & ($ millions)
Table 39. Global PretomanidTablets Revenue Market Share by Company (2021-2026)
Table 40. Global PretomanidTablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 41. Key Manufacturers PretomanidTablets Producing Area Distribution and Sales Area
Table 42. Players PretomanidTablets Products Offered
Table 43. PretomanidTablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 44. New Products and Potential Entrants
Table 45. Market M&A Activity & Strategy
Table 46. Global PretomanidTablets Sales by Geographic Region (2021-2026) & (Units)
Table 47. Global PretomanidTablets Sales Market Share Geographic Region (2021-2026)
Table 48. Global PretomanidTablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 49. Global PretomanidTablets Revenue Market Share by Geographic Region (2021-2026)
Table 50. Global PretomanidTablets Sales by Country/Region (2021-2026) & (Units)
Table 51. Global PretomanidTablets Sales Market Share by Country/Region (2021-2026)
Table 52. Global PretomanidTablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 53. Global PretomanidTablets Revenue Market Share by Country/Region (2021-2026)
Table 54. Americas PretomanidTablets Sales by Country (2021-2026) & (Units)
Table 55. Americas PretomanidTablets Sales Market Share by Country (2021-2026)
Table 56. Americas PretomanidTablets Revenue by Country (2021-2026) & ($ millions)
Table 57. Americas PretomanidTablets Sales by Type (2021-2026) & (Units)
Table 58. Americas PretomanidTablets Sales by Application (2021-2026) & (Units)
Table 59. APAC PretomanidTablets Sales by Region (2021-2026) & (Units)
Table 60. APAC PretomanidTablets Sales Market Share by Region (2021-2026)
Table 61. APAC PretomanidTablets Revenue by Region (2021-2026) & ($ millions)
Table 62. APAC PretomanidTablets Sales by Type (2021-2026) & (Units)
Table 63. APAC PretomanidTablets Sales by Application (2021-2026) & (Units)
Table 64. Europe PretomanidTablets Sales by Country (2021-2026) & (Units)
Table 65. Europe PretomanidTablets Revenue by Country (2021-2026) & ($ millions)
Table 66. Europe PretomanidTablets Sales by Type (2021-2026) & (Units)
Table 67. Europe PretomanidTablets Sales by Application (2021-2026) & (Units)
Table 68. Middle East & Africa PretomanidTablets Sales by Country (2021-2026) & (Units)
Table 69. Middle East & Africa PretomanidTablets Revenue Market Share by Country (2021-2026)
Table 70. Middle East & Africa PretomanidTablets Sales by Type (2021-2026) & (Units)
Table 71. Middle East & Africa PretomanidTablets Sales by Application (2021-2026) & (Units)
Table 72. Key Market Drivers & Growth Opportunities of PretomanidTablets
Table 73. Key Market Challenges & Risks of PretomanidTablets
Table 74. Key Industry Trends of PretomanidTablets
Table 75. PretomanidTablets Raw Material
Table 76. Key Suppliers of Raw Materials
Table 77. PretomanidTablets Distributors List
Table 78. PretomanidTablets Customer List
Table 79. Global PretomanidTablets Sales Forecast by Region (2027-2032) & (Units)
Table 80. Global PretomanidTablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Americas PretomanidTablets Sales Forecast by Country (2027-2032) & (Units)
Table 82. Americas PretomanidTablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. APAC PretomanidTablets Sales Forecast by Region (2027-2032) & (Units)
Table 84. APAC PretomanidTablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 85. Europe PretomanidTablets Sales Forecast by Country (2027-2032) & (Units)
Table 86. Europe PretomanidTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. Middle East & Africa PretomanidTablets Sales Forecast by Country (2027-2032) & (Units)
Table 88. Middle East & Africa PretomanidTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 89. Global PretomanidTablets Sales Forecast by Type (2027-2032) & (Units)
Table 90. Global PretomanidTablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 91. Global PretomanidTablets Sales Forecast by Application (2027-2032) & (Units)
Table 92. Global PretomanidTablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 93. TB Alliance Basic Information, PretomanidTablets Manufacturing Base, Sales Area and Its Competitors
Table 94. TB Alliance PretomanidTablets Product Portfolios and Specifications
Table 95. TB Alliance PretomanidTablets Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. TB Alliance Main Business
Table 97. TB Alliance Latest Developments
Table 98. Macleods Pharmaceuticals Basic Information, PretomanidTablets Manufacturing Base, Sales Area and Its Competitors
Table 99. Macleods Pharmaceuticals PretomanidTablets Product Portfolios and Specifications
Table 100. Macleods Pharmaceuticals PretomanidTablets Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Macleods Pharmaceuticals Main Business
Table 102. Macleods Pharmaceuticals Latest Developments
Table 103. Lupin Limited Basic Information, PretomanidTablets Manufacturing Base, Sales Area and Its Competitors
Table 104. Lupin Limited PretomanidTablets Product Portfolios and Specifications
Table 105. Lupin Limited PretomanidTablets Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Lupin Limited Main Business
Table 107. Lupin Limited Latest Developments
LIST OF FIGURES
Figure 1. Picture of PretomanidTablets
Figure 2. PretomanidTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global PretomanidTablets Sales Growth Rate 2021-2032 (Units)
Figure 7. Global PretomanidTablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. PretomanidTablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. PretomanidTablets Sales Market Share by Country/Region (2025)
Figure 10. PretomanidTablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 26 tablets/box
Figure 12. Product Picture of 182 tablets/bottle
Figure 13. Global PretomanidTablets Sales Market Share by Type in 2026
Figure 14. Global PretomanidTablets Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Bottle
Figure 16. Product Picture of Box
Figure 17. Global PretomanidTablets Sales Market Share by Packaging in 2026
Figure 18. Global PretomanidTablets Revenue Market Share by Packaging (2021-2026)
Figure 19. Product Picture of Protect From Light
Figure 20. Product Picture of Protect From Moisture
Figure 21. Global PretomanidTablets Sales Market Share by Storage in 2026
Figure 22. Global PretomanidTablets Revenue Market Share by Storage (2021-2026)
Figure 23. Product Picture of Innovator
Figure 24. Product Picture of Generic
Figure 25. Global PretomanidTablets Sales Market Share by Production Technology in 2026
Figure 26. Global PretomanidTablets Revenue Market Share by Production Technology (2021-2026)
Figure 27. PretomanidTablets Consumed in Multidrug-Resistant Pulmonary Tuberculosis (MDR-TB)
Figure 28. Global PretomanidTablets Market: Multidrug-Resistant Pulmonary Tuberculosis (MDR-TB) (2021-2026) & (Units)
Figure 29. PretomanidTablets Consumed in Extensively Drug-Resistant Pulmonary Tuberculosis (XDR-TB)
Figure 30. Global PretomanidTablets Market: Extensively Drug-Resistant Pulmonary Tuberculosis (XDR-TB) (2021-2026) & (Units)
Figure 31. PretomanidTablets Consumed in Others
Figure 32. Global PretomanidTablets Market: Others (2021-2026) & (Units)
Figure 33. Global PretomanidTablets Sale Market Share by Application (2025)
Figure 34. Global PretomanidTablets Revenue Market Share by Application in 2025
Figure 35. PretomanidTablets Sales by Company in 2025 (Units)
Figure 36. Global PretomanidTablets Sales Market Share by Company in 2025
Figure 37. PretomanidTablets Revenue by Company in 2025 ($ millions)
Figure 38. Global PretomanidTablets Revenue Market Share by Company in 2025
Figure 39. Global PretomanidTablets Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global PretomanidTablets Revenue Market Share by Geographic Region in 2025
Figure 41. Americas PretomanidTablets Sales 2021-2026 (Units)
Figure 42. Americas PretomanidTablets Revenue 2021-2026 ($ millions)
Figure 43. APAC PretomanidTablets Sales 2021-2026 (Units)
Figure 44. APAC PretomanidTablets Revenue 2021-2026 ($ millions)
Figure 45. Europe PretomanidTablets Sales 2021-2026 (Units)
Figure 46. Europe PretomanidTablets Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa PretomanidTablets Sales 2021-2026 (Units)
Figure 48. Middle East & Africa PretomanidTablets Revenue 2021-2026 ($ millions)
Figure 49. Americas PretomanidTablets Sales Market Share by Country in 2025
Figure 50. Americas PretomanidTablets Revenue Market Share by Country (2021-2026)
Figure 51. Americas PretomanidTablets Sales Market Share by Type (2021-2026)
Figure 52. Americas PretomanidTablets Sales Market Share by Application (2021-2026)
Figure 53. United States PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC PretomanidTablets Sales Market Share by Region in 2025
Figure 58. APAC PretomanidTablets Revenue Market Share by Region (2021-2026)
Figure 59. APAC PretomanidTablets Sales Market Share by Type (2021-2026)
Figure 60. APAC PretomanidTablets Sales Market Share by Application (2021-2026)
Figure 61. China PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 65. India PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe PretomanidTablets Sales Market Share by Country in 2025
Figure 69. Europe PretomanidTablets Revenue Market Share by Country (2021-2026)
Figure 70. Europe PretomanidTablets Sales Market Share by Type (2021-2026)
Figure 71. Europe PretomanidTablets Sales Market Share by Application (2021-2026)
Figure 72. Germany PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 73. France PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 74. UK PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa PretomanidTablets Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa PretomanidTablets Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa PretomanidTablets Sales Market Share by Application (2021-2026)
Figure 80. Egypt PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of PretomanidTablets in 2026
Figure 86. Manufacturing Process Analysis of PretomanidTablets
Figure 87. Industry Chain Structure of PretomanidTablets
Figure 88. Channels of Distribution
Figure 89. Global PretomanidTablets Sales Market Forecast by Region (2027-2032)
Figure 90. Global PretomanidTablets Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global PretomanidTablets Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global PretomanidTablets Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global PretomanidTablets Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global PretomanidTablets Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of PretomanidTablets
Figure 2. PretomanidTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global PretomanidTablets Sales Growth Rate 2021-2032 (Units)
Figure 7. Global PretomanidTablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. PretomanidTablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. PretomanidTablets Sales Market Share by Country/Region (2025)
Figure 10. PretomanidTablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 26 tablets/box
Figure 12. Product Picture of 182 tablets/bottle
Figure 13. Global PretomanidTablets Sales Market Share by Type in 2026
Figure 14. Global PretomanidTablets Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Bottle
Figure 16. Product Picture of Box
Figure 17. Global PretomanidTablets Sales Market Share by Packaging in 2026
Figure 18. Global PretomanidTablets Revenue Market Share by Packaging (2021-2026)
Figure 19. Product Picture of Protect From Light
Figure 20. Product Picture of Protect From Moisture
Figure 21. Global PretomanidTablets Sales Market Share by Storage in 2026
Figure 22. Global PretomanidTablets Revenue Market Share by Storage (2021-2026)
Figure 23. Product Picture of Innovator
Figure 24. Product Picture of Generic
Figure 25. Global PretomanidTablets Sales Market Share by Production Technology in 2026
Figure 26. Global PretomanidTablets Revenue Market Share by Production Technology (2021-2026)
Figure 27. PretomanidTablets Consumed in Multidrug-Resistant Pulmonary Tuberculosis (MDR-TB)
Figure 28. Global PretomanidTablets Market: Multidrug-Resistant Pulmonary Tuberculosis (MDR-TB) (2021-2026) & (Units)
Figure 29. PretomanidTablets Consumed in Extensively Drug-Resistant Pulmonary Tuberculosis (XDR-TB)
Figure 30. Global PretomanidTablets Market: Extensively Drug-Resistant Pulmonary Tuberculosis (XDR-TB) (2021-2026) & (Units)
Figure 31. PretomanidTablets Consumed in Others
Figure 32. Global PretomanidTablets Market: Others (2021-2026) & (Units)
Figure 33. Global PretomanidTablets Sale Market Share by Application (2025)
Figure 34. Global PretomanidTablets Revenue Market Share by Application in 2025
Figure 35. PretomanidTablets Sales by Company in 2025 (Units)
Figure 36. Global PretomanidTablets Sales Market Share by Company in 2025
Figure 37. PretomanidTablets Revenue by Company in 2025 ($ millions)
Figure 38. Global PretomanidTablets Revenue Market Share by Company in 2025
Figure 39. Global PretomanidTablets Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global PretomanidTablets Revenue Market Share by Geographic Region in 2025
Figure 41. Americas PretomanidTablets Sales 2021-2026 (Units)
Figure 42. Americas PretomanidTablets Revenue 2021-2026 ($ millions)
Figure 43. APAC PretomanidTablets Sales 2021-2026 (Units)
Figure 44. APAC PretomanidTablets Revenue 2021-2026 ($ millions)
Figure 45. Europe PretomanidTablets Sales 2021-2026 (Units)
Figure 46. Europe PretomanidTablets Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa PretomanidTablets Sales 2021-2026 (Units)
Figure 48. Middle East & Africa PretomanidTablets Revenue 2021-2026 ($ millions)
Figure 49. Americas PretomanidTablets Sales Market Share by Country in 2025
Figure 50. Americas PretomanidTablets Revenue Market Share by Country (2021-2026)
Figure 51. Americas PretomanidTablets Sales Market Share by Type (2021-2026)
Figure 52. Americas PretomanidTablets Sales Market Share by Application (2021-2026)
Figure 53. United States PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC PretomanidTablets Sales Market Share by Region in 2025
Figure 58. APAC PretomanidTablets Revenue Market Share by Region (2021-2026)
Figure 59. APAC PretomanidTablets Sales Market Share by Type (2021-2026)
Figure 60. APAC PretomanidTablets Sales Market Share by Application (2021-2026)
Figure 61. China PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 65. India PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe PretomanidTablets Sales Market Share by Country in 2025
Figure 69. Europe PretomanidTablets Revenue Market Share by Country (2021-2026)
Figure 70. Europe PretomanidTablets Sales Market Share by Type (2021-2026)
Figure 71. Europe PretomanidTablets Sales Market Share by Application (2021-2026)
Figure 72. Germany PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 73. France PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 74. UK PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa PretomanidTablets Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa PretomanidTablets Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa PretomanidTablets Sales Market Share by Application (2021-2026)
Figure 80. Egypt PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries PretomanidTablets Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of PretomanidTablets in 2026
Figure 86. Manufacturing Process Analysis of PretomanidTablets
Figure 87. Industry Chain Structure of PretomanidTablets
Figure 88. Channels of Distribution
Figure 89. Global PretomanidTablets Sales Market Forecast by Region (2027-2032)
Figure 90. Global PretomanidTablets Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global PretomanidTablets Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global PretomanidTablets Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global PretomanidTablets Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global PretomanidTablets Revenue Market Share Forecast by Application (2027-2032)
